|
Sign In to gain access to subscriptions and/or personal tools.
|
Fulminant central nervous system demyelination associated with interferon- therapy and hepatitis C virus infection
R. Höftberger
Institute of Neurology, Medical University of Vienna, Austria
F. Garzuly
Department of Pathology, Markusovszky Hospital, Szombathely, Hungary
H.P. Dienes
Department of Pathology, University of Köln, Germany
J. Grubits
Department of Neurology, Elisabeth Hospital, Sopron, Hungary
B. Rohonyi
Department of Pathology, Elisabeth Hospital, Sopron, Hungary
G. Fischer
Institute of blood group serology, Medical University of Vienna, Austria
Z. Hanzely
National Institute of Neurosurgery, Department of Neuropathology, Budapest, Hungary
H. Lassmann
Center for Brain Research, Division of Neuroimmunology, Vienna, Austria
H. Budka
Institute of Neurology, Medical University of Vienna, Austria, herbert.budka{at}meduniwien.ac.at
Hepatitis C virus (HCV) infection is common in the general population and may coincide with disease in the central and peripheral nervous system. Interferon- (IFN- ) is used as treatment for HCV infection. The therapeutic benefit is assumed to result from activation of natural killer cells and CD8+ T cells. Despite its beneficial effects, it has been associated with a number of autoimmune disorders, such as chronic inflammatory demyelinating polyneuropathy and multiple sclerosis. Several clinical reports including magnetic resonance imaging exist, but neuropathological confirmation of MS associated with IFN- therapy and HCV infection is lacking. We report a case of a female patient with chronic HCV infection who developed `acute MS'-like demyelinating disease after IFN- administration, with extensive lesions throughout brain and thoracic spinal cord. The patient died after a disease duration of 6 months. Brain autopsy revealed Baló-like demyelinating plaques with positive HCV sequences within florid lesions. The development of fulminant demyelinating disease after administration of IFN- suggests that autoimmune mechanisms such as T cell mediated tissue damage might be initiated or aggravated by IFN- therapy. Additionally, the presence of HCV RNA within the demyelinated lesion indicates a possible role in triggering or propagating disease. Multiple Sclerosis 2007; 13: 1100—1106. http://msj.sagepub.com
Key Words: CD8+ T cells concentric sclerosis (Baló) hepatitis C virus interferon- multiple sclerosis (MS)
References
- Forton DM, Karayiannis P., Mahmud N., Taylor-Robinson SD, Thomas HC Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004; 78: 5170—83.[Abstract/Free Full Text]
- Radkowski M., Wilkinson J., Nowicki M., Adair D., Vargas H., Ingui C. et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 2002; 76: 600—608.[Abstract/Free Full Text]
- Luft T., Pang KC, Thomas E., Hertzog P., Hart DN, Trapani J. et al. Type I. IFNs enhance the terminal differentiation of dendritic cells. J Immunol 1998; 161: 1947—53.[Abstract/Free Full Text]
- Nissen MH, Larsen JK, Plesner T., Olesen BK, Ernst P. Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells. Clin Exp Immunol 1987; 69: 632—38.[Web of Science][Medline]
[Order article via Infotrieve]
- Stadelmann C., Ludwin S., Tabira T., Guseo A., Lucchinetti CF, Leel-Ossy L. et al. Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis. Brain 2005; 128: 979—87.[Abstract/Free Full Text]
- Dries V., von Both I., Muller M., Gerken G., Schirmacher P., Odenthal M. et al. Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology 1999; 29: 223—29.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fries JW, Roth T., Dienes HP, Weber M., Odenthal M. A novel evaluation method for paraffinized human renal biopsies using quantitative analysis of microdissected glomeruli and VCAM-1 as marker of inflammatory mesangial cell activation. Nephrol Dial Transplant 2003; 18: 710—16.[Abstract/Free Full Text]
- Aboul-Enein F., Rauschka H., Kornek B., Stadelmann C., Stefferl A., Bruck W. et al. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 2003; 62: 25—33.[Web of Science][Medline]
[Order article via Infotrieve]
- Preziati D., La Rosa L., Covini G., Marcelli R., Rescalli S., Persani L. et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol 1995; 132: 587—93.[Abstract/Free Full Text]
- Kataoka I., Shinagawa K., Shiro Y., Okamoto S., Watanabe R., Mori T. et al. Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia. Am J Hematol 2002; 70: 149—53.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Matsuo T., Takabatake R. Multiple sclerosis-like disease secondary to alpha interferon. Ocul Immunol Inflamm 2002; 10: 299—304.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Friese MA, Fugger L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 2005; 128: 1747—63.[Abstract/Free Full Text]
- Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707—17.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hayashi T., Morimoto C., Burks JS, Kerr C., Hauser SL Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens. Ann Neurol 1988; 24: 523—31.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nyland H., Mork S., Matre R. In-situ characterization of mononuclear cell infiltrates in lesions of multiple sclerosis. Neuropathol Appl Neurobiol 1982; 8: 403—11.[Web of Science][Medline]
[Order article via Infotrieve]
- Booss J., Esiri MM, Tourtellotte WW, Mason DY Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 1983; 62: 219—32.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gay FW, Drye TJ, Dick GW, Esiri MM The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 1997; 120: 1461—83.[Abstract/Free Full Text]
- Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R. et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000; 192: 393—404.[Abstract/Free Full Text]
- Ferguson B., Matyszak MK, Esiri MM, Perry VH Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393—99.[Abstract/Free Full Text]
- Kornek B., Lassmann H. Axonal pathology in multiple sclerosis. A historical note. Brain Pathol 1999; 9: 651—56.[Web of Science][Medline]
[Order article via Infotrieve]
- Trapp BD, Peterson J., Ransohoff RM, Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278—85.[Abstract/Free Full Text]
- Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000; 123: 1174—83.[Abstract/Free Full Text]
- Aboul-Enein F., Lassmann H. Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? Acta Neuropathol (Berl) 2005; 109: 49—55.[CrossRef][Medline]
[Order article via Infotrieve]
- Laskus T., Radkowski M., Bednarska A., Wilkinson J., Adair D., Nowicki M. et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol 2002; 76: 10064—68.[Abstract/Free Full Text]
- Wucherpfennig KW, Strominger JL Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695—705.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Julien J., Vital C., Vallat JM, Lagueny A., Deminiere C., Darriet D. Polyneuropathy in Waldenstrom's macroglobulinemia. Deposition of M component on myelin sheaths. Arch Neurol 1978; 35: 423—25.[Abstract/Free Full Text]
- Durelli L., Bongioanni MR, Cavallo R., Ferrero B., Ferri R., Ferrio MF et al. Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis. Neurology 1994; 44: 406—13.[Abstract/Free Full Text]
- Camenga DL, Johnson KP, Alter M., Engelhardt CD, Fishman PS, Greenstein JI et al. Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis. Arch Neurol 1986; 43: 1239—46.[Web of Science][Medline]
[Order article via Infotrieve]
- Larrey D., Marcellin P., Freneaux E., Pessayre D., Benhamou JP Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa. JAMA 1989; 261: 2065.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Corcia P., Barbereau D., Guennoc AM, de Toffol B., Bacq Y. Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy. Neurology 2004; 63: 179—80.[Abstract/Free Full Text]
- Caudai C., Maimone D., Almi P., Annunziata P., Bastianoni I., Boggiano CA et al. The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C. Gut 1997; 41: 411—12.[Abstract/Free Full Text]
- Heckmann JG, Kayser C., Heuss D., Manger B., Blum HE, Neundorfer B. Neurological manifestations of chronic hepatitis C. J Neurol 1999; 246: 486—91.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Authier FJ, Bassez G., Payan C., Guillevin L., Pawlotsky JM, Degos JD et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology 2003; 60: 808—12.[Abstract/Free Full Text]
- Sobukawa E., Sakimura K., Hoshino S., Hoshino M., Miyoshi K. Hepatic myelopathy: an unusual neurological complication of advanced hepatic disease. Intern Med 1994; 33: 718—22.[Web of Science][Medline]
[Order article via Infotrieve]
- Zandman-Goddard G., Levy Y., Weiss P., Shoenfeld Y., Langevitz P. Transverse myelitis associated with chronic hepatitis C. Clin Exp Rheumatol 2003; 21: 111—13.[Web of Science][Medline]
[Order article via Infotrieve]
- Grewal AK, Lopes MB, Berg CL, Bennett AK, Alves VA, Trugman JM Recurrent demyelinating myelitis associated with hepatitis C viral infection. J Neurol Sci 2004; 224: 101—106.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nolte CH, Endres AS, Meisel H. Sensory ataxia in myelopathy with chronic hepatitis C virus infection. Neurology 2002; 59: 958.[Free Full Text]
- Bolay H., Soylemezoglu F., Nurlu G., Tuncer S.,Varli K. PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity. Clin Neurol Neurosurg 1996; 98: 305—308.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Vargas HE, Laskus T., Radkowski M., Wilkinson J., Balan V., Douglas DD et al. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl 2002; 8: 1014—19.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Maggi F., Giorgi M., Fornai C., Morrica A., Vatteroni ML, Pistello M. et al. Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol 1999; 5: 319—23.[Web of Science][Medline]
[Order article via Infotrieve]
- Sacconi S., Salviati L., Merelli E. Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch Neurol 2001; 58: 1679—81.[Abstract/Free Full Text]
- Fujita H., Chuganji Y., Yaginuma M., Momoi M., Tanaka T. Case report: acute encephalitis immediately prior to acute onset of hepatitis C virus infection. J Gastroenterol Hepatol 1999; 14: 1129—31.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Anthoney DA, Bone I., Evans TR Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant melanoma. Ann Oncol 2000; 11: 1197—200.[Abstract/Free Full Text]
- Meriggioli MN, Rowin J. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Muscle Nerve 2000; 23: 433—35.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Multiple Sclerosis, Vol. 13, No. 9,
1100-1106 (2007)
DOI: 10.1177/1352458507078684

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C.-F. Hsieh, C.-K. Liu, T.-J. Fang, Y.-H. Yu, C.-L. Lai, and H.-K. Kuo
Previous Hepatitis A Virus Infection Is Related to Slower Psychomotor Speed in Elderly Adults
J Gerontol A Biol Sci Med Sci,
October 1, 2009;
64A(10):
1090 - 1096.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|